Covered recipient · General Payments record
MARK ANTOSH
General Payments · PY2018–2024
$4,531.48
- Reported across 160 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $299.33 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $136.23 | 10 |
| Astellas Pharma US Inc | $59.11 | 2 |
| PFIZER INC. | $47.47 | 2 |
| Axonics Modulation Technologies, Inc. | $27.69 | 1 |
| Exact Sciences Corporation | $14.57 | 1 |
| MILLICENT US INC | $14.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.15 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103232021 | CMS |
| ABBVIE INC. | $26.31 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103232023 | CMS |
| ABBVIE INC. | $4.96 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103232025 | CMS |
| ABBVIE INC. | $5.12 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103232027 | CMS |
| ABBVIE INC. | $13.96 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103232029 | CMS |
| ABBVIE INC. | $25.77 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103232031 | CMS |
| ABBVIE INC. | $4.74 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103232033 | CMS |
| ABBVIE INC. | $22.10 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103232035 | CMS |
| ABBVIE INC. | $7.50 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103232037 | CMS |
| ABBVIE INC. | $12.62 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103232039 | CMS |
| Astellas Pharma US Inc | $26.02 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139287402 | CMS |
| Astellas Pharma US Inc | $33.09 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139282288 | CMS |
| Axonics, Inc. | $27.69 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142357832 | CMS |
| Exact Sciences Corporation | $14.57 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128382822 | CMS |
| MILLICENT US INC | $14.26 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150904314 | CMS |
| PFIZER INC. | $25.36 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131177287 | CMS |
| PFIZER INC. | $22.11 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131710507 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.